Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Targeted cancer treatment: resisting arrest

Many individuals with chronic myeloid leukemia have benefited from the drug imatinib (Gleevec)—but if they are taken off the drug, relapse occurs. Two mathematical models to explain this phenomenon, one described in this issue, have come to different conclusions (1181–1184).

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Dynamics of CML treatment with imatinib.

Kim Caesar

References

  1. Smith, J.K., Mamoon, N.M. & Duhe, R.J. Oncol. Res. 14, 175–225 (2004).

    Article  Google Scholar 

  2. Druker, B.J. Adv. Cancer Res. 91, 1–30 (2004).

    Article  CAS  Google Scholar 

  3. Gorre, M.E. et al. Science 293, 876–880 (2001).

    Article  CAS  Google Scholar 

  4. Cortes, J., O'Brien, S. & Kantarjian, H. Blood 104, 2204–2205 (2004).

    Article  CAS  Google Scholar 

  5. Higashi, T. et al. Am. J. Hematol. 76, 275–278 (2004).

    Article  CAS  Google Scholar 

  6. Michor, F. et al. Nature 435, 1267–1270 (2005).

    Article  CAS  Google Scholar 

  7. Roeder, I. et al. Nat. Med. 12, 1181–1184 (2006).

    Article  CAS  Google Scholar 

  8. Melo, J.V., Hughes, T.P. & Apperley, J.F. Hematology Am. Soc. Hematol. Educ. Program 2003, 132–152 (2003).

    Article  Google Scholar 

  9. Wodarz, D. & Komarova, N.L. Computational Biology of Cancer: Lecture Notes and Mathematical Modeling (World Scientific Publishing, Singapore, 2005).

    Book  Google Scholar 

  10. Graham, S.M. et al. Blood 99, 319–325 (2002).

    Article  CAS  Google Scholar 

  11. Jorgensen, H.G. et al. Clin. Cancer Res. 12, 626–633 (2006).

    Article  CAS  Google Scholar 

  12. Komarova, N.L. & Wodarz, D. Proc. Natl. Acad. Sci. USA 102, 9714–9719 (2005).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wodarz, D. Targeted cancer treatment: resisting arrest. Nat Med 12, 1125–1126 (2006). https://doi.org/10.1038/nm1006-1125

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1006-1125

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing